Health and Fitness Health and Fitness
Mon, January 9, 2012
[ Mon, Jan 09th 2012 ] - Market Wire
Mindray Medical Announces Preliminary 2011 Operat .. ng Results and Provides 2012 Net Revenue Guidance
[ Mon, Jan 09th 2012 ] - Market Wire
Genomic Health Announces Initiation of Clinical V .. ancer Test;; Acceleration of Next Generati
[ Mon, Jan 09th 2012 ] - Market Wire
CareFusion Announces Preliminary Second Quarter Results
[ Mon, Jan 09th 2012 ] - Market Wire
Optimer Pharmaceuticals Provides Update on DIFICID (fidaxomicin) Tablets Launch
[ Mon, Jan 09th 2012 ] - Market Wire
Mindray Medical Exceeds 2011 Product Development Targets and Announces Strong 2012 Pipeline
[ Mon, Jan 09th 2012 ] - Market Wire
Thallion and LFB Complete Patient Enrollment of Phase II SHIGATEC Trial
[ Mon, Jan 09th 2012 ] - Market Wire
SecureAlert Reports Record Annual Revenue and Gross Profit Margin
[ Mon, Jan 09th 2012 ] - Market Wire
Mylan Confirms First-to-File Patent Challenge Relating to Actoplus Met XR Tablets
[ Mon, Jan 09th 2012 ] - Market Wire
Data From Phase 3 AFFIRM Trial of MDV3100 in Adva .. ghlighted in Late-Breaking Presentation at ASCO G
[ Mon, Jan 09th 2012 ] - Market Wire
Idenix Reports Advancement of HCV Development Pipeline
[ Mon, Jan 09th 2012 ] - Market Wire
Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184
[ Mon, Jan 09th 2012 ] - Market Wire
Adherex Provides Patient Enrollment Update for Ph .. 2 Study of Eniluracil in Metastatic Breast Cancer
[ Mon, Jan 09th 2012 ] - Market Wire
Sangamo BioSciences Announces Initiation of Two New Phase 2 HIV Clinical Trials
[ Mon, Jan 09th 2012 ] - Market Wire
SciClone Provides 2011 Financial Update and Initial 2012 Guidance
[ Mon, Jan 09th 2012 ] - Market Wire
VIVUS Provides Qnexa Regulatory Update
[ Mon, Jan 09th 2012 ] - Market Wire
Solta Medical Affirms Q4 2011 Financial Outlook
[ Mon, Jan 09th 2012 ] - Market Wire
PAREXEL International to Present at J.P. Morgan Healthcare Conference
[ Mon, Jan 09th 2012 ] - Market Wire
Cord Blood America's Argentina Company, BioCells, Opens Franchise in Brazil
[ Mon, Jan 09th 2012 ] - Market Wire
Comprehensive Care Corporation Announces Completi .. alth Provider Network Build Out Serving Puerto Ri
Sun, January 8, 2012
[ Sun, Jan 08th 2012 ] - Market Wire
Helix BioPharma Corp. Appoints Jack Kay as Chairm .. Kazimierz Roszkowski-Sliz as European Medical Di
[ Sun, Jan 08th 2012 ] - Market Wire
GSK and Theravance Announce Initial Outcomes From .. s for Once-Daily Relovair(TM)* in COPD and Asthma
[ Sun, Jan 08th 2012 ] - Market Wire
Ion Torrent Delivers on Unparalleled Speed, Simpl .. d Scalability Enabled by Semiconductor Technology
[ Sun, Jan 08th 2012 ] - Market Wire
Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
Sat, January 7, 2012
[ Sat, Jan 07th 2012 ] - Market Wire
Gilead Sciences annuncia la conclusione anticipat .. di attesa previsto dalla legge Hart-Scott-Rodino
[ Sat, Jan 07th 2012 ] - Market Wire
Gilead Sciences gibt frhzeitiges Ende der Warteperiode gem Hart-Scott-Rodino bekannt
[ Sat, Jan 07th 2012 ] - Market Wire
Gilead Sciences maakt vroege beindiging bekend van Hart-Scott-Rodino wachtperiode
Fri, January 6, 2012
[ Fri, Jan 06th 2012 ] - Market Wire
Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period
[ Fri, Jan 06th 2012 ] - Market Wire
Synta Pharmaceuticals Prices Public Offering of Common Stock
[ Fri, Jan 06th 2012 ] - Market Wire
Thermo Fisher Scientific Introduces Unity Lab Services
[ Fri, Jan 06th 2012 ] - Market Wire
Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D.

Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D.


Published on 2012-01-06 21:42:50 - Market Wire
  Print publication without navigation


Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D. -- SAN DIEGO, Jan. 7, 2012 /PRNewswire/ --

Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D.

[ ]

SAN DIEGO, Jan. 7, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: [ NBIX ]) is sad to announce that its academic founder and member of the Board of Directors, Wylie W. Vale, Ph.D. passed away earlier this week.  He was a thoughtful leader with an incredible scientific mind who will be sorely missed.  "Wylie's intellect was matched by his terrific wit and disarming good nature.  He was a good friend," said Kevin Gorman, President and Chief Executive Officer of Neurocrine.  The entire Neurocrine team mourns his passing and extends its sympathies to the Vale family.

 

 

SOURCE Neurocrine Biosciences, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.neurocrine.com ]

Contributing Sources